Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine

International Journal of Radiation Biology

Volumn 84, Issue 8, 2008, Pages 623-634

  Paunesku, David ^a   Paunesku, Tatjana ^a   Wahl, Andrew ^a   Kataoka, Yasushi ^c   Murley, Jeffrey ^c   Grdina, David J ^c   Woloschak, Gayle E ^a,b,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amifostine; Fission neutron and gamma ray irradiation; Late tissue toxicity

Indexed keywords

AMIFOSTINE; PHOSPHOROTHIOIC ACID S 3 (3 METHYLAMINOPROPYLAMINO)PROPYL ESTER;

ADRENAL DISEASE; ADRENAL TUMOR; ARTICLE; ASCITES; BLEEDING; BRAIN TOXICITY; CONTROLLED STUDY; DIVERTICULOSIS; FEMALE; FISSION NEUTRON; GAMMA RADIATION; HEPATITIS; HYDROTHORAX; HYPOPHYSIS TUMOR; INCIDENCE; KIDNEY TUMOR; LIVER TOXICITY; LIVER TUMOR; LYMPHOMA; MALE; MOUSE; NEUTRON RADIATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; VASCULAR TUMOR; WHOLE BODY RADIATION;

AMIFOSTINE; ANIMALS; FEMALE; GAMMA RAYS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUTRONS; ORGANOTHIOPHOSPHORUS COMPOUNDS; RADIATION-PROTECTIVE AGENTS; WHOLE-BODY IRRADIATION;

ANIMALIA; MUS;

EID: 48249127986     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000802241762     Document Type: Article

References (32)

1. Antonadou D, Pepelassi M, Synodinou M, Puglisi M, Throuvalas N. 2002. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. International Journal of Radiation Oncology Biology Physics 52:739-747.
2. Brown PE. 1967. Mechanism of action of aminothiol radioprotectors. Nature 213:363-364.
3. Calabro-Jones PM, Fahey RC, Smoluk GD, Ward JF. 1985. Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V 79-171 cells incubated in medium containing WR-2721. International Journal of Radiation Biology & Related Studies in Physics, Chemistry, and Medicine 47:23-27.
4. Capizzi RL. 1999. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine. Seminars in Oncology 26:3-21.
5. Glover D, Fox KR, Weiler C, Kligerman MM, Turrisi A, Glick JH. 1988. Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy. Pharmacological Therapy 39:3-7.
6. Grdina DJ, Carnes BA, Nagy B. 1992. Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons. Advances in Space Research 12:257-263.
7. Grdina DJ, Nagy B, Hill CK, Wells RL, Peraino C. 1985. The radioprotector WR-1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis 6:929-931.
8. Grdina DJ, Sigdestad CP, Carnes BA. 1989. Protection by WR1065 and WR151326 against fission-neutron-induced mutations at the HGPRT locus in V79 cells. Radiation Research 117:500-510.
9. Grdina DJ, Wright BJ, Carnes BA. 1991. Protection against late effects of radiation by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Research 51:4125-4130.
10. Hall EJ, Giaccia JA. 2005. Radiobiology for the radiologist. Baltimore, MD: Lippincott, Williams and Wilkins Publishing.
11. Hanson WR, Grdina DJ. 1987. Radiation-induced DNA Single-strand breaks in the intestinal mucosal cells of mice treated with the radioprotectors WR-2721 or 16-16 dimethyl prostaglandin E2. International Journal of Radiation Biology 52:67-76.
12. Hunter NR, Guttenberger R, Milas L. 1992. Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721. International Journal of Radiation Oncology Biology Physics 22:795-798.
13. Jeong WI, Do SH, Kim TH, Jeong DH, Hong IH, Ki MR, Kwak DM, Lee SS, Jee YH, Kim SB. 2007. acute effects of fast neutron irradiation on mouse liver. Journal of Radiation Research 48:233-240.
14. Kataoka Y, Basic I, Perrin J, Grdina DJ. 1992. Antimutagenic effects of radioprotector WR-2721 against fission-spectrum neurons and 60Co gamma-rays in mice. International Journal of Radiation Biology 61:387-392.
15. Kataoka Y, Murley JS, Baker KL, Grdina DJ. 2007. Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugs. Radiation Research 168:106-114.
16. Liu SC, Murley JS, Woloschak G, Grdina DJ. 1997. Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine. Carcinogenesis 18:2457-2459.
17. Maisin JR, Gerber GB, Vankerkom J, Wambersie A. 1996. Survival and diseases in C57BL mice exposed to X-rays or 3.1 MeV neutrons at an age of 7 or 21 days. Radiation Research 146:453-460.
18. Maisin JR, Mattelin G, Lambiet-Collier M. 1977. Chemical protection against the long-term effects of a single whole-body exposure of mice to ionizing radiation: I. Life shortening. Radiation Research 71:119-131.
19. Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. 2007. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis. International Journal of Radiation Oncology Biology Physics 68:111-118.
20. Milas L, Hunter N, Stephens LC, Peters LJ. 1984. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Research 44:5567-5569.
21. Milas L, Murray D, Brock WA, Meyn RE. 1988. Radioprotectors in tumor radiotherapy: Factors and settings determining therapeutic ratio. Pharmacology & Therapeutics 39:179-187.
22. Murley JS, Kataoka Y, Baker KL, Diamond AM, Morgan WF, Grdina DJ. 2007. Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha. Radiation Research 167:465-474.
23. Provinciali M, Ciavattini A, Di Stefano G, Argentati K, Garzetti GG. 1999. In vivo amifostine (WR-2721) prevents chemotherapy-induced apoptosis of peripheral blood lymphocytes from cancer patients. Life Science 64:1525-1532.
24. Ramakrishnan N. 1992. N-(2-mercaptoethyl)-1, 3-propanediamine (WR-1065) protects thymocytes from programmed cell death. The Journal of Immunology 148:1817-1821.
25. 35S-WR-2721 Biodistribution. Radiation Research 97:598-607.
26. 60Co g-ray and fission-spectrum neutron-induced chromosome damage in V79 cells. Radiation Research 113:145-154.
27. Takahashi T. 1992. 252Cf relative biological effectiveness and inheritable effect of fission neutrons in mouse liver tumorigenesis. Cancer Research 52:1948-1953.
28. Van Beek ME, Doak RL, Sigdestad CP, Grdina DJ. 1990. Pathological effects of the radiation protector WR-151327 in mice. Radiation Research 124:79-84.
29. Walker RI. 1988. Requirements of radioprotectors for military and emergency needs. Pharmacological Therapy 39:13-20.
30. Yuhas JM. 1980. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)- ethylphosphorothioic acid. Cancer Research 40:1519-1524.
31. Yuhas JM, Storer JB. 1969a. Differential chemoprotection of normal and malignant tissues. Journal of the National Cancer Institute 42:331-335.
32. Yuhas JM, Storer JB. 1969b. Chemoprotection against three modes of radiation death in the mouse. International Journal of Radiation Biology 15.